Protocol for Venoarterial ExtraCorporeal Membrane Oxygenation to Reduce Morbidity and Mortality Following Bilateral Lung TransPlantation: the ECMOToP Randomised Controlled Trial

Overview

Journal BMJ Open

Specialty General Medicine

Date 2024 Mar 6

PMID 38448059

Authors

Jonathan Messika

Philippine Eloy

David Boulate

Aude Charvet

Julien Fessler

Jacques Jougon

Philippe Lacoste

Olaf Mercier

Philippe Portran

Hadrien Roze

Edouard Sage

Jacques Thes

Francois Tronc

Mickael Vourch

Philippe Montravers

Yves Castier

Herve Mal

Pierre Mordant

Affiliations

Soon will be listed here.

Abstract

Introduction: Lung transplantation (LTx) aims at improving survival and quality of life for patients with end-stage lung diseases. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is used as intraoperative support for LTx, despite no precise guidelines for its initiation. We aim to evaluate two strategies of VA-ECMO initiation in the perioperative period in patients with obstructive or restrictive lung disease requiring bilateral LTx. In the control 'on-demand' arm, high haemodynamic and respiratory needs will dictate VA-ECMO initiation; in the experimental 'systematic' arm, VA-ECMO will be pre-emptively initiated. We hypothesise a 'systematic' strategy will increase the number of ventilatory-free days at day 28.

Methods And Analysis: We designed a multicentre randomised controlled trial in parallel groups. Adult patients with obstructive or restrictive lung disease requiring bilateral LTx, without a formal indication for pre-emptive VA-ECMO before LTx, will be included. Patients with preoperative pulmonary hypertension with haemodynamic collapse, ECMO as a bridge to transplantation, severe hypoxaemia or hypercarbia will be secondarily excluded. In the systematic group, VA-ECMO will be systematically implanted before the first pulmonary artery cross-clamp. In the on-demand group, VA-ECMO will be implanted intraoperatively if haemodynamic or respiratory indices meet preplanned criteria. Non-inclusion, secondary exclusion and VA-ECMO initiation criteria were validated by a Delphi process among investigators. Postoperative weaning of ECMO and mechanical ventilation will be managed according to best practice guidelines. The number of ventilator-free days at 28 days (primary endpoint) will be compared between the two groups in the intention-to-treat population. Secondary endpoints encompass organ failure occurrence, day 28, day 90 and year 1 vital status, and adverse events.

Ethics And Dissemination: The sponsor is the Assistance Publique-Hôpitaux de Paris. The ECMOToP protocol version 2.1 was approved by Comité de Protection des Personnes Ile de France VIII. Results will be published in international peer-reviewed medical journals.

Trial Registration Number: NCT05664204.

References

Fessler J, Sage E, Roux A, Feliot E, Gayat E, Pirracchio R . Is Extracorporeal Membrane Oxygenation Withdrawal a Safe Option After Double-Lung Transplantation?. Ann Thorac Surg. 2020; 110(4):1167-1174. DOI: 10.1016/j.athoracsur.2020.03.077. View

Bouadma L, Sonneville R, Garrouste-Orgeas M, Darmon M, Souweine B, Voiriot G . Ventilator-Associated Events: Prevalence, Outcome, and Relationship With Ventilator-Associated Pneumonia. Crit Care Med. 2015; 43(9):1798-806. DOI: 10.1097/CCM.0000000000001091. View

Kuchinke W, Ohmann C, Yang Q, Salas N, Lauritsen J, Gueyffier F . Heterogeneity prevails: the state of clinical trial data management in Europe - results of a survey of ECRIN centres. Trials. 2010; 11:79. PMC: 2918594. DOI: 10.1186/1745-6215-11-79. View

Magouliotis D, Tasiopoulou V, Svokos A, Svokos K, Zacharoulis D . Extracorporeal membrane oxygenation versus cardiopulmonary bypass during lung transplantation: a meta-analysis. Gen Thorac Cardiovasc Surg. 2017; 66(1):38-47. DOI: 10.1007/s11748-017-0836-3. View

Oto T, Levvey B, Whitford H, Griffiths A, Kotsimbos T, Williams T . Feasibility and utility of a lung donor score: correlation with early post-transplant outcomes. Ann Thorac Surg. 2006; 83(1):257-63. DOI: 10.1016/j.athoracsur.2006.07.040. View

. Uniform requirements for manuscripts submitted to biomedical journals. N Engl J Med. 1997; 336(4):309-15. DOI: 10.1056/NEJM199701233360422. View

Snell G, Yusen R, Weill D, Strueber M, Garrity E, Reed A . Report of the ISHLT Working Group on Primary Lung Graft Dysfunction, part I: Definition and grading-A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2017; 36(10):1097-1103. DOI: 10.1016/j.healun.2017.07.021. View

Hoetzenecker K, Schwarz S, Muckenhuber M, Benazzo A, Frommlet F, Schweiger T . Intraoperative extracorporeal membrane oxygenation and the possibility of postoperative prolongation improve survival in bilateral lung transplantation. J Thorac Cardiovasc Surg. 2018; 155(5):2193-2206.e3. DOI: 10.1016/j.jtcvs.2017.10.144. View

Crespo M, McCarthy D, Hopkins P, Clark S, Budev M, Bermudez C . ISHLT Consensus Statement on adult and pediatric airway complications after lung transplantation: Definitions, grading system, and therapeutics. J Heart Lung Transplant. 2018; 37(5):548-563. DOI: 10.1016/j.healun.2018.01.1309. View

10.

Ius F, Aburahma K, Boethig D, Salman J, Sommer W, Draeger H . Long-term outcomes after intraoperative extracorporeal membrane oxygenation during lung transplantation. J Heart Lung Transplant. 2020; 39(9):915-925. DOI: 10.1016/j.healun.2020.04.020. View

11.

Messika J, Eloy P, Roux A, Hirschi S, Nieves A, Le Pavec J . COVID-19 in Lung Transplant Recipients. Transplantation. 2020; 105(1):177-186. DOI: 10.1097/TP.0000000000003508. View

12.

Dutau H, Vandemoortele T, Laroumagne S, Gomez C, Boussaud V, Cavailles A . A new endoscopic standardized grading system for macroscopic central airway complications following lung transplantation: the MDS classification. Eur J Cardiothorac Surg. 2013; 45(2):e33-8. DOI: 10.1093/ejcts/ezt499. View

13.

Aigner C, Wisser W, Taghavi S, Lang G, Jaksch P, Czyzewski D . Institutional experience with extracorporeal membrane oxygenation in lung transplantation. Eur J Cardiothorac Surg. 2007; 31(3):468-73. DOI: 10.1016/j.ejcts.2006.11.049. View

14.

Garner J, Jarvis W, Emori T, Horan T, Hughes J . CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988; 16(3):128-40. DOI: 10.1016/0196-6553(88)90053-3. View

15.

Hoetzenecker K, Benazzo A, Stork T, Sinn K, Schwarz S, Schweiger T . Bilateral lung transplantation on intraoperative extracorporeal membrane oxygenator: An observational study. J Thorac Cardiovasc Surg. 2020; 160(1):320-327.e1. DOI: 10.1016/j.jtcvs.2019.10.155. View

16.

Moser B, Jaksch P, Taghavi S, Murakozy G, Lang G, Hager H . Lung transplantation for idiopathic pulmonary arterial hypertension on intraoperative and postoperatively prolonged extracorporeal membrane oxygenation provides optimally controlled reperfusion and excellent outcome. Eur J Cardiothorac Surg. 2017; 53(1):178-185. PMC: 5848802. DOI: 10.1093/ejcts/ezx212. View

17.

Hansson L, Hedner T, Dahlof B . Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point. Blood Press. 1992; 1(2):113-9. DOI: 10.3109/08037059209077502. View

18.

McCarthy C, Behravesh S, Naidu S, Oklu R . Air Embolism: Practical Tips for Prevention and Treatment. J Clin Med. 2016; 5(11). PMC: 5126790. DOI: 10.3390/jcm5110093. View

19.

Le Gall A, Follin A, Cholley B, Mantz J, Aissaoui N, Pirracchio R . Veno-arterial-ECMO in the intensive care unit: From technical aspects to clinical practice. Anaesth Crit Care Pain Med. 2017; 37(3):259-268. DOI: 10.1016/j.accpm.2017.08.007. View

20.

Boasquevisque C, Yildirim E, Waddel T, Keshavjee S . Surgical techniques: lung transplant and lung volume reduction. Proc Am Thorac Soc. 2009; 6(1):66-78. DOI: 10.1513/pats.200808-083GO. View